Growing understanding of the complex and multifactorial etiology of AD has driven the development of mechanism-based strategies targeting amyloid-beta (Aβ) plaques, Tau protein deposits, apolipoprotein-E (ApoE) function, neuroprotection or neuroinflammation (Cummings et al., 2021). The gene discussed is APOE; the disease is Alzheimer disease.